IP Verse

Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-Sialylation

Patent No. EP3144318 (titled "Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-Sialylation") was filed by Ferring on Apr 16, 2009. The application was issued on Sep 23, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ARES TRADINGMar 25, 2021WEICKMANN & WEICKMANN PARTMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3144318

FERRING
Application Number
EP16194925A
Filing Date
Apr 16, 2009
Status
Opposition Rejected
Sep 6, 2024
Publication Date
Sep 23, 2020
External Links
Slate, Register , Google Patents